Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal HemoglobinuriaPeter Hillmen, Russell P. Rother, Matthew Cullen et al.|New England Journal of Medicine|2004Cited by 637
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survivalRichard Kelly, Peter Hillmen, Anita Hill et al.|Blood|2011Cited by 514
Clonal hematopoiesis is not significantly associated with COVID-19 disease severityYifan Zhou, George S. Vassiliou, Ruba Shalhoub et al.|Blood|2022Cited by 25